CATALYST PHARMACEUTICALS, INC. CPRX Income Statement

Catalyst pharmaceuticals, inc. (CPRX)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenues:
Product revenue, net
118,994	102,306	0	0	0	-	-	-	0	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	0	0	-	-	-
Operating costs and expenses:
Cost of sales
17,198	14,759	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development
19,757	18,842	20,951	20,892	19,968	19,919	14,906	13,073	11,820	11,375	10,791	10,580	10,637	11,369	12,380	12,929	12,998	11,801	10,353	10,197	9,718	10,117	9,801	9,720	9,753	8,096	6,773	4,623	3,024	2,659	2,875	2,834	3,207	3,383	2,923	3,107	0	0	0
Selling, general and administrative
38,527	36,881	32,398	27,974	21,618	15,875	11,056	9,014	8,112	7,304	6,690	6,509	7,085	7,910	8,776	9,331	9,345	8,597	7,836	7,084	5,656	4,473	3,512	2,731	2,361	2,214	2,336	2,524	2,537	2,561	2,875	2,763	2,720	2,698	2,032	2,050	0	0	0
Total operating costs and expenses
75,483	70,483	63,710	54,840	43,297	35,795	25,963	22,087	19,933	18,679	17,482	17,089	17,722	19,280	21,157	22,261	22,343	20,398	18,190	17,282	15,374	14,591	13,314	12,451	12,114	10,311	9,110	7,148	5,561	5,221	5,750	5,597	5,927	6,082	4,956	5,158	0	0	0
Operating income (loss)
43,510	31,823	8,973	-13,054	-30,349	-35,295	-25,963	-22,087	-19,933	-18,679	-17,482	-17,089	-17,722	-19,280	-21,157	-22,261	-22,343	-20,398	-18,190	-17,282	-15,374	-14,591	-13,314	-12,451	-12,114	-10,311	-9,110	-7,148	-5,561	-5,221	-5,750	-5,597	-5,927	-6,082	-4,956	-5,158	0	0	0
Other income, net
1,578	1,585	1,530	1,481	1,401	1,291	1,072	857	577	454	374	311	313	321	264	244	156	100	135	94	105	76	76	80	73	47	34	27	20	14	7	8	10	10	13	14	0	0	0
Change in fair value of warrants liability
-	-	-	-	-	-	-	-	-	186	79	186	244	-886	-1,168	-1,797	-1,978	-65	-147	1,281	1,838	993	135	1,905	2,180	1,890	-300	-1,636	-1,358	-1,129	0	0	0	-	-	-	-	-	-
Net income (loss) before income taxes
45,089	33,409	10,504	-11,573	-28,948	-34,003	-24,891	-21,230	-19,145	-18,412	-17,187	-16,964	-17,653	-18,072	-19,724	-20,219	-20,208	-20,232	-17,907	-18,468	-17,108	-15,509	-13,373	-14,275	-14,221	-12,154	-10,876	-7,585	-4,731	-4,076	-6,351	-4,858	-5,963	-6,391	-4,943	-5,143	0	0	0
Provision for income taxes
0	-	0	0	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Net income (loss)
42,945	31,875	9,446	-12,023	-28,948	-34,003	-24,891	-21,230	-19,145	-18,412	-17,187	-16,964	-17,653	-18,072	-19,724	-20,219	-20,208	-20,232	-17,907	-18,468	-17,108	-15,509	-13,373	-14,275	-14,221	-12,154	-10,876	-7,585	-4,731	-4,076	-6,351	-4,858	-5,963	-6,391	-4,943	-5,143	0	0	0
Net income (loss) per share:
Basic
0.10	0.08	0.13	0.11	-0.01	-	-0.08	-0.06	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted
0.10	0.08	0.13	0.10	-0.01	-	-0.08	-0.06	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average shares outstanding:
Basic
103,407	103,186	102,974	102,869	102,747	-	102,641	102,596	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted
106,534	108,361	107,045	105,928	102,747	-	102,641	102,596	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share - basic and diluted
-	-	-	-	-	-	-	-	-0.06	-0.05	-0.05	-0.05	-0.06	-0.04	-0.05	-0.06	-0.07	-0.07	-0.05	-0.06	-0.07	-0.05	-0.07	-0.05	-0.07	-0.02	-0.13	-0.08	-0.04	-0.01	-0.08	-0.01	-0.04	-0.10	-0.05	-0.06	-0.08	-0.05	-0.07
Weighted average shares outstanding - basic and diluted
-	-	-	-	-	-	-	-	102,557	91,533	84,797	83,905	82,972	82,899	82,870	82,870	82,860	82,886	82,470	82,037	76,039	69,094	67,169	66,167	54,138	54,257	44,686	41,445	41,420	36,437	32,132	26,851	24,710	23,681	21,654	21,654	19,922	18,821	18,043
Net income (loss)
42,945	31,875	9,446	-12,023	-28,948	-34,003	-23,681	-19,722	0	-18,412	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other comprehensive income (loss):
Unrealized gain (loss) on available-for-sale securities
90	29	65	58	15	-20	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Comprehensive income (loss)
43,036	31,905	9,511	-11,964	-28,932	-34,023	-24,937	-21,266	-19,166	-18,412	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-